Anatomic patterns of relapse and progression following treatment with I-131-MIBG in relapsed or refractory neuroblastoma

Ben Kenan, RF; Polishchuk, AL; Hawkins, RA; Braunstein, SE; Matthay, KK; DuBois, SG; Haas-Kogan, DA

Haas-Kogan, DA (通讯作者),Harvard Med Sch, Dana Farber Canc Inst, Boston Childrens Hosp, Dept Radiat Oncol,Brigham & Womens Hosp, 450 Brookline Ave,D1622, Boston, MA 02215 USA.

PEDIATRIC BLOOD & CANCER, 2022; 69 (2):

Abstract

Objectives Patients with metaiodobenzylguanidine (MIBG)-avid relapsed or refractory neuroblastoma after initial therapy may exhibit transient response......

Full Text Link